Literature DB >> 22179617

C-terminal modification of osteopontin inhibits interaction with the αVβ3-integrin.

Brian Christensen1, Eva Kläning, Mette S Nielsen, Mikkel H Andersen, Esben S Sørensen.   

Abstract

Osteopontin (OPN) is a multifunctional phosphorylated protein containing the integrin binding sequence Arg-Gly-Asp through which it interacts with several integrin receptors, such as the α(V)β(3)-integrin. OPN exists in many different isoforms differing in phosphorylation status that are likely to interact differently with integrins. The C-terminal region of OPN is particularly well conserved among mammalian species, which suggests an important functional role of this region. In this study, we show that modification of the extreme C terminus of OPN plays an important regulatory role for the interaction with the α(V)β(3)-integrin. It is demonstrated that highly phosphorylated OPN has a much reduced capability to promote cell adhesion via the α(V)β(3)-integrin compared with lesser phosphorylated forms. The cell attachment promoted by highly phosphorylated OPN could be greatly increased by both dephosphorylation and proteolytic removal of the C terminus. Using recombinantly expressed OPN containing a tag in the N or C terminus, it is shown that a modification in the C-terminal part significantly reduces the adhesion of cells to OPN via the α(V)β(3)-integrin, whereas modification of the N terminus does not influence the binding. The inhibited binding of the α(V)β(3)-integrin to OPN could be restored by proteolytic removal of the C terminus by thrombin and plasmin. These data illustrate a novel mechanism regulating the interaction of OPN and the α(V)β(3)-integrin by modification of the highly conserved C-terminal region of the protein.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22179617      PMCID: PMC3281738          DOI: 10.1074/jbc.M111.277996

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  Phosphorylation-dependent interaction of osteopontin with its receptors regulates macrophage migration and activation.

Authors:  Georg F Weber; Samer Zawaideh; Sherry Hikita; Vikram A Kumar; Harvey Cantor; Samy Ashkar
Journal:  J Leukoc Biol       Date:  2002-10       Impact factor: 4.962

2.  The integrin alpha(9)beta(1) binds to a novel recognition sequence (SVVYGLR) in the thrombin-cleaved amino-terminal fragment of osteopontin.

Authors:  Y Yokosaki; N Matsuura; T Sasaki; I Murakami; H Schneider; S Higashiyama; Y Saitoh; M Yamakido; Y Taooka; D Sheppard
Journal:  J Biol Chem       Date:  1999-12-17       Impact factor: 5.157

3.  Osteopontin, a novel substrate for matrix metalloproteinase-3 (stromelysin-1) and matrix metalloproteinase-7 (matrilysin).

Authors:  R Agnihotri; H C Crawford; H Haro; L M Matrisian; M C Havrda; L Liaw
Journal:  J Biol Chem       Date:  2001-05-25       Impact factor: 5.157

4.  Post-translationally modified residues of native human osteopontin are located in clusters: identification of 36 phosphorylation and five O-glycosylation sites and their biological implications.

Authors:  Brian Christensen; Mette S Nielsen; Kim F Haselmann; Torben E Petersen; Esben S Sørensen
Journal:  Biochem J       Date:  2005-08-15       Impact factor: 3.857

5.  The metastasis-associated extracellular matrix protein osteopontin forms transient structure in ligand interaction sites.

Authors:  Gerald Platzer; Andreas Schedlbauer; Angela Chemelli; Przemyslaw Ozdowy; Nicolas Coudevylle; Renate Auer; Georg Kontaxis; Markus Hartl; Andrew J Miles; B A Wallace; Otto Glatter; Klaus Bister; Robert Konrat
Journal:  Biochemistry       Date:  2011-06-16       Impact factor: 3.162

6.  NMR characterization of intramolecular interaction of osteopontin, an intrinsically disordered protein with cryptic integrin-binding motifs.

Authors:  Yoshiki Yamaguchi; Shinya Hanashima; Hirokazu Yagi; Yutaka Takahashi; Hiroaki Sasakawa; Eiji Kurimoto; Takeshi Iguchi; Shigeyuki Kon; Toshimitsu Uede; Koichi Kato
Journal:  Biochem Biophys Res Commun       Date:  2010-02-10       Impact factor: 3.575

7.  Dephosphorylation of osteopontin and bone sialoprotein by osteoclastic tartrate-resistant acid phosphatase. Modulation of osteoclast adhesion in vitro.

Authors:  B Ek-Rylander; M Flores; M Wendel; D Heinegård; G Andersson
Journal:  J Biol Chem       Date:  1994-05-27       Impact factor: 5.157

8.  Secreted phosphoproteins associated with neoplastic transformation: close homology with plasma proteins cleaved during blood coagulation.

Authors:  D R Senger; C A Perruzzi; C F Gracey; A Papadopoulos; D G Tenen
Journal:  Cancer Res       Date:  1988-10-15       Impact factor: 12.701

Review 9.  Control of osteopontin signaling and function by post-translational phosphorylation and protein folding.

Authors:  Christian C Kazanecki; Dana J Uzwiak; David T Denhardt
Journal:  J Cell Biochem       Date:  2007-11-01       Impact factor: 4.429

10.  Adhesive properties of osteopontin: regulation by a naturally occurring thrombin-cleavage in close proximity to the GRGDS cell-binding domain.

Authors:  D R Senger; C A Perruzzi; A Papadopoulos-Sergiou; L Van de Water
Journal:  Mol Biol Cell       Date:  1994-05       Impact factor: 4.138

View more
  21 in total

1.  Osteopontin regulates dentin and alveolar bone development and mineralization.

Authors:  B L Foster; M Ao; C R Salmon; M B Chavez; T N Kolli; A B Tran; E Y Chu; K R Kantovitz; M Yadav; S Narisawa; J L Millán; F H Nociti; M J Somerman
Journal:  Bone       Date:  2017-12-05       Impact factor: 4.398

2.  Angiotensin 1-7, but not the thrombin-cleaved osteopontin C-terminal fragment, attenuates osteopontin-mediated macrophage-induced endothelial-cell inflammation.

Authors:  Rachel Hamias; Assaf Rudich; George Greenberg; Gabriel Szendro; Talya Wolak
Journal:  Inflamm Res       Date:  2017-11-27       Impact factor: 4.575

Review 3.  Macrophages-Key cells in the response to wear debris from joint replacements.

Authors:  Christophe Nich; Yuya Takakubo; Jukka Pajarinen; Mari Ainola; Abdelhakim Salem; Tarvo Sillat; Allison J Rao; Milan Raska; Yasunobu Tamaki; Michiaki Takagi; Yrjö T Konttinen; Stuart B Goodman; Jiri Gallo
Journal:  J Biomed Mater Res A       Date:  2013-04-09       Impact factor: 4.396

4.  Thrombin cleavage of osteopontin disrupts a pro-chemotactic sequence for dendritic cells, which is compensated by the release of its pro-chemotactic C-terminal fragment.

Authors:  Zhifei Shao; John Morser; Lawrence L K Leung
Journal:  J Biol Chem       Date:  2014-08-11       Impact factor: 5.157

5.  Osteopontin binding to the alpha 4 integrin requires highest affinity integrin conformation, but is independent of post-translational modifications of osteopontin.

Authors:  Tommy Hui; Esben S Sørensen; Susan R Rittling
Journal:  Matrix Biol       Date:  2014-11-29       Impact factor: 11.583

6.  Overlapping functions of bone sialoprotein and pyrophosphate regulators in directing cementogenesis.

Authors:  M Ao; M B Chavez; E Y Chu; K C Hemstreet; Y Yin; M C Yadav; J L Millán; L W Fisher; H A Goldberg; M J Somerman; B L Foster
Journal:  Bone       Date:  2017-09-01       Impact factor: 4.398

7.  Thioredoxin-like protein 2 is overexpressed in colon cancer and promotes cancer cell metastasis by interaction with ran.

Authors:  Yuanyuan Lu; Xiaodi Zhao; Kai Li; Guanhong Luo; Yongzhan Nie; Yongquan Shi; Yi Zhou; Gui Ren; Bin Feng; Zhenxiong Liu; Yan Pan; Ting Li; Xuegang Guo; Kaichun Wu; Antonio Miranda-Vizuete; Xin Wang; Daiming Fan
Journal:  Antioxid Redox Signal       Date:  2013-03-04       Impact factor: 8.401

Review 8.  Osteopontin in Immune-mediated Diseases.

Authors:  S R Rittling; R Singh
Journal:  J Dent Res       Date:  2015-09-04       Impact factor: 6.116

9.  Milk osteopontin, a nutritional approach to prevent alcohol-induced liver injury.

Authors:  Xiaodong Ge; Yongke Lu; Tung-Ming Leung; Esben S Sørensen; Natalia Nieto
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-03-21       Impact factor: 4.052

10.  Phosphorylation of osteopontin in osteoarthritis degenerative cartilage and its effect on matrix metalloprotease 13.

Authors:  Mai Xu; Lu Zhang; Lei Zhao; Shuguang Gao; Rui Han; Dazhi Su; Guanghua Lei
Journal:  Rheumatol Int       Date:  2012-11-07       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.